Search research articles
Contact Us
Filters
Showing results (251-260 of 269) with videos related to
Page
of 27
Sort By:
Diseases of the Colon and Rectum
|
January 6, 2022
Anal Adenocarcinoma: A Rare Entity in Need of Multidisciplinary Management
Jelena Lukovic, J John Kim, Zhihui Amy Liu, et al.
Journal for Immunotherapy of Cancer
|
June 15, 2022
Increase in serum choline levels predicts for improved progression-free survival (PFS) in patients with advanced cancers receiving pembrolizumab
Geoffrey Alan Watson, Enrique Sanz-Garcia, Wen-Jiang Zhang, et al.
Journal of Medicinal Chemistry
|
September 19, 2018
Application of Virtual Screening to the Identification of New LpxC Inhibitor Chemotypes, Oxazolidinone and Isoxazoline
Patrick S Lee, Guillaume Lapointe, Ann Marie Madera, et al.
Nature Communications
|
May 22, 2024
Post-COVID conditions following COVID-19 vaccination: a retrospective matched cohort study of patients with SARS-CoV-2 infection
Debbie E Malden, In-Lu Amy Liu, Lei Qian, et al.
Cancer Discovery
|
February 23, 2024
Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors
Eric Y Stutheit-Zhao, Enrique Sanz-Garcia, Zhihui Amy Liu, et al.
JCO Precision Oncology
|
August 23, 2024
Combined Transcriptome and Circulating Tumor DNA Longitudinal Biomarker Analysis Associates With Clinical Outcomes in Advanced Solid Tumors Treated With Pembrolizumab
Alberto Hernando-Calvo, S Y Cindy Yang, Maria Vila-Casadesús, et al.
Breast Cancer Research : BCR
|
July 13, 2021
Intraoperative fluorescence imaging with aminolevulinic acid detects grossly occult breast cancer: a phase II randomized controlled trial
Kathryn Ottolino-Perry, Anam Shahid, Stephanie DeLuca, et al.
NPJ Precision Oncology
|
February 13, 2026
Clinical validation of a tissue-agnostic genome-wide methylome enrichment assay to monitor response to pembrolizumab
Eric Y Stutheit-Zhao, Yongqi Zhong, Collin A Melton, et al.
Breast Cancer Research and Treatment
|
May 5, 2025
Chronic skin toxicities in breast cancer survivors: a systematic review and meta-analysis of radiotherapy techniques
Shing Fung Lee, Henry C Y Wong, Jolien Robijns, et al.
Contemporary Clinical Trials
|
October 24, 2025
The TRaditional versus Early Aggressive Therapy for Multiple Sclerosis (TREAT-MS) trial: design and baseline characteristics of participants
Ellen M Mowry, Peiqing Qian, William Meador, et al.
Page
of 27
Search research articles
Search
Showing results (251-260 of 269) with videos related to
Sort By:
Page
of 27
Diseases of the Colon and Rectum
|
January 6, 2022
Anal Adenocarcinoma: A Rare Entity in Need of Multidisciplinary Management
Jelena Lukovic, J John Kim, Zhihui Amy Liu, et al.
Journal for Immunotherapy of Cancer
|
June 15, 2022
Increase in serum choline levels predicts for improved progression-free survival (PFS) in patients with advanced cancers receiving pembrolizumab
Geoffrey Alan Watson, Enrique Sanz-Garcia, Wen-Jiang Zhang, et al.
Journal of Medicinal Chemistry
|
September 19, 2018
Application of Virtual Screening to the Identification of New LpxC Inhibitor Chemotypes, Oxazolidinone and Isoxazoline
Patrick S Lee, Guillaume Lapointe, Ann Marie Madera, et al.
Nature Communications
|
May 22, 2024
Post-COVID conditions following COVID-19 vaccination: a retrospective matched cohort study of patients with SARS-CoV-2 infection
Debbie E Malden, In-Lu Amy Liu, Lei Qian, et al.
Cancer Discovery
|
February 23, 2024
Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors
Eric Y Stutheit-Zhao, Enrique Sanz-Garcia, Zhihui Amy Liu, et al.
JCO Precision Oncology
|
August 23, 2024
Combined Transcriptome and Circulating Tumor DNA Longitudinal Biomarker Analysis Associates With Clinical Outcomes in Advanced Solid Tumors Treated With Pembrolizumab
Alberto Hernando-Calvo, S Y Cindy Yang, Maria Vila-Casadesús, et al.
Breast Cancer Research : BCR
|
July 13, 2021
Intraoperative fluorescence imaging with aminolevulinic acid detects grossly occult breast cancer: a phase II randomized controlled trial
Kathryn Ottolino-Perry, Anam Shahid, Stephanie DeLuca, et al.
NPJ Precision Oncology
|
February 13, 2026
Clinical validation of a tissue-agnostic genome-wide methylome enrichment assay to monitor response to pembrolizumab
Eric Y Stutheit-Zhao, Yongqi Zhong, Collin A Melton, et al.
Breast Cancer Research and Treatment
|
May 5, 2025
Chronic skin toxicities in breast cancer survivors: a systematic review and meta-analysis of radiotherapy techniques
Shing Fung Lee, Henry C Y Wong, Jolien Robijns, et al.
Contemporary Clinical Trials
|
October 24, 2025
The TRaditional versus Early Aggressive Therapy for Multiple Sclerosis (TREAT-MS) trial: design and baseline characteristics of participants
Ellen M Mowry, Peiqing Qian, William Meador, et al.
Page
of 27